The Worldwide Corneal Transplantation Industry is Expected to Reach $640 Million by 2028 - ResearchAndMarkets.com
Retrieved on:
月曜日, 3月 21, 2022
Health, Optical, Surgery, People, Degenerative disease, Eye, CAGR, Conjunction (grammar), Corneal transplantation, World Health Organization, WHO, DMEK, Growth, Corneal ulcer, Severe cognitive impairment, Keratitis, World, Hospital, Incidence, Keratoconus, Onchocerciasis, Leprosy, Industry, Corneal opacity, Time, COVID-19, Trichiasis, Fuchs' dystrophy, Cornea, RNIB, Epidemiology, Royal National Institute of Blind People, Patient, Pharmaceutical industry, Marketing, Trachoma, Xerophthalmia
The corneal transplantation market is projected to reach $640.79 million by 2028 from $420.71 million in 2021; it is estimated to grow at a CAGR of 6.2% during 2021-2028.
Key Points:
- The corneal transplantation market is projected to reach $640.79 million by 2028 from $420.71 million in 2021; it is estimated to grow at a CAGR of 6.2% during 2021-2028.
- However, the risks associated with Corneal Transplantation and shortage of donor material hampers the market growth.
- Corneal blindness has complex epidemiology that includes a broad spectrum of infectious and inflammatory eye diseases causing corneal scars that contribute to functional blindness.
- Trachoma, corneal ulcers, ophthalmia neonatorum, xerophthalmia, viral infections, onchocerciasis, leprosy, traditional eye medications, and eye injuries lead to corneal blindness.